Products
In this classification, Blastomyces dermatitidis serological reagents are devices used in test to identify specific Blastomyces dermatitidis antibodies in serum. US FDA regulates Blastomyces dermatitidis serological reagents under 21 CFR 866.3060 and under FDA product code LSH.
How AGI delivers it
Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.
For Blastomyces dermatitidisserological reagents, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.
Get the professional outcome delivered as software, priced on results, not headcount.
For Blastomyces dermatitidisserological reagents, get the professional outcome delivered as software, priced on results, not headcount.
Value flow
Go deeper